Removing clinic barriers to rapid initiation of ART in Uganda enables 70% to start on the same day
Dolutegravir safe and highly effective in older children
TAF/emtricitabine maintains viral suppression as well as TDF regimens with less bone and kidney toxicity
Botswana close to reaching the 90-90-90 testing and treatment targets
Starting HIV treatment at first clinic visit improves outcomes in African study
Bone density recovers quickly after stopping PrEP
Dose-finding trials of antibody-based drugs for HIV prevention will start soon
Long-acting injectable cabotegravir + rilpivirine works well as HIV maintenance therapy
Early antiretroviral therapy has no impact on marker of early cardiovascular disease
